Benefits of pharmacist intervention in the critical care patients with infectious diseases: A propensity score matching retrospective cohort study.

[1]  K. Kwon,et al.  Core Elements for Successful Implementation of Antimicrobial Stewardship Programs , 2021, Infection & chemotherapy.

[2]  G. Suh,et al.  Impact on Patient Outcomes of Pharmacist Participation in Multidisciplinary Critical Care Teams: A Systematic Review and Meta-Analysis. , 2019, Critical care medicine.

[3]  S. Fazio,et al.  The Role of the Clinical Pharmacist in a Preventive Cardiology Practice , 2019, The Annals of pharmacotherapy.

[4]  P. Elbers,et al.  Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study , 2019, Critical Care.

[5]  Bridgette L. Kram,et al.  Medication Histories in Critically Ill Patients Completed by Pharmacy Personnel , 2019, The Annals of pharmacotherapy.

[6]  J. Morton,et al.  Role of the Pharmacist in Antimicrobial Stewardship. , 2018, The Medical clinics of North America.

[7]  S. Marušić,et al.  Pharmacist’s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial , 2018, International Journal of Clinical Pharmacy.

[8]  B. Demoré,et al.  Pharmacist participation in antimicrobial stewardship in Australian and French hospitals: a cross-sectional nationwide survey , 2018, The Journal of antimicrobial chemotherapy.

[9]  E. Ely,et al.  Critical Care Pharmacists and Medication Management in an ICU Recovery Center , 2018, The Annals of pharmacotherapy.

[10]  M. Martinez-Alonso,et al.  A Before-and-After Study of the Effectiveness of an Antimicrobial Stewardship Program in Critical Care , 2018, Antimicrobial Agents and Chemotherapy.

[11]  Tri-Long Nguyen,et al.  Impact of Quality Bundle Enforcement by a Critical Care Pharmacist on Patient Outcome and Costs* , 2017, Critical care medicine.

[12]  Matthew H Samore,et al.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  B. Jia,et al.  Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  Y. Koh,et al.  Current Status of Intensive Care Units Registered as Critical Care Subspecialty Training Hospitals in Korea , 2014, Journal of Korean medical science.

[15]  M. Kollef.  Antibiotics for the critically ill: more than just selecting appropriate initial therapy , 2013, Critical Care.

[16]  C. Diazgranados.  Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes. , 2012, American journal of infection control.

[17]  M. Wise,et al.  Minimising drug errors in critically ill patients , 2011, Critical care.

[18]  R. MacLaren,et al.  Effects of Pharmacist Participation in Intensive Care Units on Clinical and Economic Outcomes of Critically Ill Patients with Thromboembolic or Infarction‐Related Events , 2009, Pharmacotherapy.

[19]  C. A. Bond,et al.  Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections* , 2008, Critical care medicine.

[20]  M. Kollef.  Optimizing antibiotic therapy in the intensive care unit setting , 2001, Critical care.

[21]  J. Rotschafer,et al.  Intensive care unit antimicrobial resistance and the role of the pharmacist , 2001, Critical care medicine.

[22]  D. Bates,et al.  Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. , 1999, JAMA.

[23]  D. Cook,et al.  Impact of a clinical pharmacist in a multidisciplinary intensive care unit , 1994, Critical care medicine.

[24]  C I Miyagawa,et al.  Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit. , 1986, American journal of hospital pharmacy.

[25]  Jann B Skelton,et al.  DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes. , 2012, Journal of the American Pharmacists Association : JAPhA.

[26]  Cai Li-jing.  Retrospect and Prospect of the Development of Clinical Pharmacy in China , 2010 .